Sudipto Dolui1,2, Ze Wang3,4, Russell T Shinohara5, David A Wolk2, John A Detre1,2. 1. Department of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania, USA. 2. Department of Neurology, University of Pennsylvania, Philadelphia, Pennsylvania, USA. 3. Center for Cognition and Brain Disorders and the Affiliated Hospital, Hangzhou Normal University, Hangzhou, China. 4. Departments of Psychiatry and Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. 5. Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Abstract
PURPOSE: To propose and validate Structural Correlation-based Outlier REjection (SCORE), a novel algorithm for removal of artifacts arising from outlier control-label pairs in 2D arterial spin labeling (ASL) data. MATERIALS AND METHODS: The proposed method was assessed with respect to other state-of-the-art ASL signal processing approaches using 2D pulsed ASL data obtained with a 3T Siemens scanner from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database. Longitudinal data from control participants acquired 3 months apart were used to assess within-subject coefficient of variation (wsCV) based on the assumption that the optimal signal processing strategy will minimize control subject retest variability in Cerebral Blood Flow (CBF). SCORE was further evaluated by determining its sensitivity for distinguishing patients with Alzheimer's disease (AD) from controls based on hypoperfusion in predefined regions of interest (ROIs) that are known to be sensitive to AD-related changes. RESULTS: SCORE coupled with a preprocessing step to discard a few extreme outliers (combined algorithm referred to as SCORE+) reduced wsCV up to 21% in gray matter and 39% in smaller ROIs compared to the reference algorithms. It also provided an average increase in effect size for patient-control differences of 50% compared to other algorithms in a priori ROIs sensitive to AD-related changes. This increase was statistically significant (P < 0.05) for the majority of the ROIs and methods as evaluated by permutation tests. CONCLUSION: CBF maps generated with SCORE or SCORE + provide improved retest reliability in control subjects while simultaneously increasing sensitivity to pathological CBF effects between controls and patients. J. Magn. Reson. Imaging 2016 Level of Evidence: 2 J. MAGN. RESON. IMAGING 2017;45:1786-1797.
PURPOSE: To propose and validate Structural Correlation-based Outlier REjection (SCORE), a novel algorithm for removal of artifacts arising from outlier control-label pairs in 2D arterial spin labeling (ASL) data. MATERIALS AND METHODS: The proposed method was assessed with respect to other state-of-the-art ASL signal processing approaches using 2D pulsed ASL data obtained with a 3T Siemens scanner from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database. Longitudinal data from control participants acquired 3 months apart were used to assess within-subject coefficient of variation (wsCV) based on the assumption that the optimal signal processing strategy will minimize control subject retest variability in Cerebral Blood Flow (CBF). SCORE was further evaluated by determining its sensitivity for distinguishing patients with Alzheimer's disease (AD) from controls based on hypoperfusion in predefined regions of interest (ROIs) that are known to be sensitive to AD-related changes. RESULTS: SCORE coupled with a preprocessing step to discard a few extreme outliers (combined algorithm referred to as SCORE+) reduced wsCV up to 21% in gray matter and 39% in smaller ROIs compared to the reference algorithms. It also provided an average increase in effect size for patient-control differences of 50% compared to other algorithms in a priori ROIs sensitive to AD-related changes. This increase was statistically significant (P < 0.05) for the majority of the ROIs and methods as evaluated by permutation tests. CONCLUSION: CBF maps generated with SCORE or SCORE + provide improved retest reliability in control subjects while simultaneously increasing sensitivity to pathological CBF effects between controls and patients. J. Magn. Reson. Imaging 2016 Level of Evidence: 2 J. MAGN. RESON. IMAGING 2017;45:1786-1797.
Authors: María A Fernández-Seara; Ze Wang; Jiongjiong Wang; Heng-Yi Rao; Matthias Guenther; David A Feinberg; John A Detre Journal: Magn Reson Med Date: 2005-11 Impact factor: 4.668
Authors: Ze Wang; Geoffrey K Aguirre; Hengyi Rao; Jiongjiong Wang; María A Fernández-Seara; Anna R Childress; John A Detre Journal: Magn Reson Imaging Date: 2007-09-10 Impact factor: 2.546
Authors: Sina Aslan; Feng Xu; Peiying L Wang; Jinsoo Uh; Uma S Yezhuvath; Matthias van Osch; Hanzhang Lu Journal: Magn Reson Med Date: 2010-03 Impact factor: 4.668
Authors: A T Du; G H Jahng; S Hayasaka; J H Kramer; H J Rosen; M L Gorno-Tempini; K P Rankin; B L Miller; M W Weiner; N Schuff Journal: Neurology Date: 2006-10-10 Impact factor: 9.910
Authors: Y Chen; D A Wolk; J S Reddin; M Korczykowski; P M Martinez; E S Musiek; A B Newberg; P Julin; S E Arnold; J H Greenberg; J A Detre Journal: Neurology Date: 2011-11-16 Impact factor: 9.910
Authors: Peiying Liu; Charlamaine Parkinson; Dengrong Jiang; Minhui Ouyang; Jill B De Vis; Frances J Northington; Aylin Tekes; Hao Huang; Thierry A G M Huisman; W Christopher Golden Journal: NMR Biomed Date: 2019-04-30 Impact factor: 4.044
Authors: Manjula Kurella Tamura; Sarah Gaussoin; Nicholas M Pajewski; Greg Zaharchuk; Barry I Freedman; Stephen R Rapp; Alexander P Auchus; William E Haley; Suzanne Oparil; Jessica Kendrick; Christianne L Roumie; Srinivasan Beddhu; Alfred K Cheung; Jeff D Williamson; John A Detre; Sudipto Dolui; R Nick Bryan; Ilya M Nasrallah Journal: Am J Kidney Dis Date: 2021-09-17 Impact factor: 11.072
Authors: Azeez Adebimpe; Maxwell Bertolero; Sudipto Dolui; Matthew Cieslak; Kristin Murtha; Erica B Baller; Bradley Boeve; Adam Boxer; Ellyn R Butler; Phil Cook; Stan Colcombe; Sydney Covitz; Christos Davatzikos; Diego G Davila; Mark A Elliott; Matthew W Flounders; Alexandre R Franco; Raquel E Gur; Ruben C Gur; Basma Jaber; Corey McMillian; Michael Milham; Henk J M M Mutsaerts; Desmond J Oathes; Christopher A Olm; Jeffrey S Phillips; Will Tackett; David R Roalf; Howard Rosen; Tinashe M Tapera; M Dylan Tisdall; Dale Zhou; Oscar Esteban; Russell A Poldrack; John A Detre; Theodore D Satterthwaite Journal: Nat Methods Date: 2022-06-10 Impact factor: 47.990
Authors: Justine E F Moonen; Ilya M Nasrallah; John A Detre; Sudipto Dolui; Guray Erus; Christos Davatzikos; Osorio Meirelles; R Nick Bryan; Lenore J Launer Journal: Alzheimers Dement Date: 2022-02-09 Impact factor: 16.655
Authors: Long Xie; Sandhitsu R Das; Arun Pilania; Molly Daffner; Grace E Stockbower; Sudipto Dolui; Paul A Yushkevich; John A Detre; David A Wolk Journal: Hippocampus Date: 2018-11-06 Impact factor: 3.899
Authors: Jeffrey B Ware; Sudipto Dolui; Jeffrey Duda; Naomi Gaggi; Robin Choi; John Detre; John Whyte; Ramon Diaz-Arrastia; Junghoon J Kim Journal: J Neurotrauma Date: 2020-06-11 Impact factor: 4.869
Authors: Sudipto Dolui; Dylan Tisdall; Marta Vidorreta; David R Jacobs; Ilya M Nasrallah; R Nick Bryan; David A Wolk; John A Detre Journal: Neuroimage Clin Date: 2019-06-12 Impact factor: 4.881